Pay in 4 interest-free payments of $7.10 Learn more
Ships within 48 hours · Estimated delivery Aug 24 - Aug 29
Retatrutide, because it adds glucagon receptor activation, may cause additional metabolic effects that neither semaglutide nor tirzepatide produce, including greater fat oxidation and potentially different hunger pattern changes
These findings underscore the enhanced therapeutic potential of dual incretin receptor activation in achieving robust and sustained metabolic improvements
Here is what went into this page specifically: I pulled the full text of the SURMOUNT-5 head-to-head trial published in the New England Journal of Medicine on May 11, 2025 (DOI: 10.1056/NEJMoa2416394) and cross-referenced it with the Phase 3 TRIUMPH-4 topline readout from Eli Lilly on December 11, 2025
Prime IV Hydration & Wellness AOD-9604 Peptide Therapy Optimum Peak Wellness
What Is the Chemical Makeup of Retatrutide (60 mg)
US$ 28.46
US$ 25.90
US$ 20.56
